Published in Obesity and Diabetes Week, September 15th, 2003
Schotzinger, who will also serve on BioStratum's board of directors, joined Biostratum in November 2000 as VP and chief medical officer and was appointed president and chief operating officer in October 2002.
Prior to joining BioStratum, Schotzinger held positions of increasing responsibility at Abbott Laboratories. Commenting on Schotzinger's promotion, J. William Freytag, PhD, chairman of BioStratum's board of directors, said, "Since Bob joined BioStratum, we have been impressed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week